In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Zepbound® (Tirzepatide, Injectable pen) by Eli Lilly has been FDA-approved since 2023 for Chronic weight management. Weight Method offers a separate option for South San Francisco residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month — same pricing regardless of location.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · South San Francisco is already seeing results
Zepbound in South San Francisco, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in South San Francisco from $329/month with virtual consultations and direct-to-door shipping.
For many people in South San Francisco, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide addresses hormonal drivers involved in body weight regulation. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved in 2023 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The program is priced at $329/month, including the evaluation, the medication, ongoing care, and home delivery to South San Francisco.
Research suggests Tirzepatide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In South San Francisco, Weight Method pairs compounded Tirzepatide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $329/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.